Athersys Incorporated, alongside its collaborators Case Western Reserve University (CWRU) and Center for Stem Cell and Regeneration Medicine (CSCRM), recently announced that it was granted $1 million through the Ohio Third Frontier Biomedical Program, which supports spinal cord injury research. The project aims to enhance the preclinical study of MultiStem, the company’s proprietary stem cell product.
The company and a group of CWRU researchers, headed by neurologist Dr. Jerry Silver, discovered that MultiStem decreases the inflammation that occurs after an injury in the spinal cord....
